| Financial Year |
September 30 2020 |
| Monetary Funds |
373,071,794.65 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
140,445,041.74 |
| Accounts Receivable |
1,301,503,838.22 |
| Advances to Suppliers |
703,295,880.85 |
| Other Receivables |
42,409,312.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,414,862,181.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,163,872.43 |
| Total Current Assets |
4,026,776,133.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
179,101,176.47 |
| Investment Properties |
188,728,782.89 |
| Fixed Assetes |
948,921,901.73 |
| Under-construction Projects |
30,059,428.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
249,748,519.86 |
| R&D expenses |
5,321,849.67 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
42,069,496.26 |
| Deferred Income Tax Assets |
20,567,048.75 |
| Other Non-Current Assets |
27,088,860.02 |
| Sub-Total of Non-Current Assets |
1,771,181,784.28 |
| Total Assets |
5,797,957,917.39 |
| Short-Term Loans |
2,105,044,640.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
310,807,113.91 |
| Accounts Payable |
939,679,572.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
34,897,068.40 |
| Taxes Payable |
138,727,687.60 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
835,531,995.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
50,138,652.05 |
| Other Current Liabilities |
162,266,532.73 |
| Sub-Total of Current Liabilities |
4,927,543,038.33 |
| Long-term Loans |
264,815,949.32 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
65,238,471.46 |
| Other Non-Current Liabilities |
32,415,225.24 |
| Sub-Total of Non-Current Liabilities |
448,402,160.29 |
| Total Liabilities |
5,375,945,198.62 |
| Paid-In Capital(Or Share Stock) |
521,791,700.00 |
| Capital Surplus |
2,150,240,353.63 |
| Surplus Reserve |
8,966,292.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,938,585,579.21 |
| Minority Stockholder's Interest |
635,400,837.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-213,388,118.81 |
| Owner's Equity（Stockholder's Equity） |
422,012,718.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,797,957,917.39 |
